申请人:Aebi Johannes
公开号:US20100016282A1
公开(公告)日:2010-01-21
The invention is concerned with novel heterocyclyl compounds of formula (I)
wherein A, X, Y
1
, Y
2
, Y
3
, R
3
, R
4
, R
5
, R
6
, R
7
, R
8
, R
9
, R
10
, m, n and p are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR2 receptor, CCR5 receptor and/or CCR3 receptor and can be used as medicaments.
该发明涉及式(I)的新异环丙基化合物,其中A、X、Y1、Y2、Y3、R3、R4、R5、R6、R7、R8、R9、R10、m、n和p的定义如描述和索赔中所述,并且其生理上可接受的盐。这些化合物是CCR2受体、CCR5受体和/或CCR3受体的拮抗剂,可以用作药物。